Universidade Federal de Goias
ufg.brTotal trials
42
Active
2
Phase 3
3
Total enrollment
3,548
Read this sponsor's pipeline like an analyst.
Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.
~15-30 sec · cached for 24h
Pipeline matrix
Showing 2 of 2 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Ketamine 50 MG/ML | — | — | — | — | — | 1 | |
| Midazolam Hcl 2Mg/Ml Syrup | — | — | — | — | — | 1 |
Next readouts
- 2025-02-28
Top conditions
- Edentulous Mouth4
- Aging3
- Mouth, Edentulous3
- Complete Edentulism3
- Child Behavior3
- Breast Cancer2
- Hypertension2
- Sleep2
Frequently asked questions about Universidade Federal de Goias
- How many clinical trials does Universidade Federal de Goias have on ClinicalTrials.gov?
- Universidade Federal de Goias is listed as the lead sponsor on 42 clinical trials in ClinicalTrials.gov, 2 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Universidade Federal de Goias's trials are in Phase 3?
- 3 of Universidade Federal de Goias's trials are in Phase 3, spread across 2 active drug programs.
- What therapeutic areas does Universidade Federal de Goias focus on?
- Universidade Federal de Goias's most-studied conditions on ClinicalTrials.gov are Edentulous Mouth, Aging, Mouth, Edentulous, Complete Edentulism, Child Behavior.
- When are Universidade Federal de Goias's next clinical trial readouts?
- Universidade Federal de Goias has 1 upcoming primary-completion readout tracked here; the soonest is “Sedation Versus Protective Stabilization for Pediatric Dental Treatment”, expected around 2025-02-28.